Abstract |
Accumulating evidence suggests that elevated inflammation contributes to the pathophysiology of post-traumatic stress disorder ( PTSD) and that anti-inflammatory drugs might be a new treatment strategy for PTSD. It has been reported that beta-hydroxybutyrate (BHB), one of the main ketone bodies produced, can have an anti-inflammatory and antidepressant effect. Here, we investigated the potential anti-anxiety and anti-inflammatory effects of BHB using a rodent PTSD model, induced by single prolonged stress (SPS). Male, Sprague-Dawley rats were employed in this study. Repeated administration of BHB attenuated SPS-induced anxiety-related behaviors evaluated by the elevated plus maze test. SPS increased the serum levels of TNF-α and IL-1β. In contrast, BHB administration partially attenuated the increase of serum TNF-α. These findings demonstrate that BHB exerts its anxiolytic effects, possibly by inhibiting systemic TNF-α. Hence, BHB may be a novel therapeutic candidate for the treatment of PTSD.
|
Authors | Takehiko Yamanashi, Masaaki Iwata, Midori Shibushita, Kyohei Tsunetomi, Mayu Nagata, Naofumi Kajitani, Akihiko Miura, Ryoichi Matsuo, Tsuyoshi Nishiguchi, Takahiro A Kato, Daiki Setoyama, Yukihiko Shirayama, Ken Watanabe, Gen Shinozaki, Koichi Kaneko |
Journal | Scientific reports
(Sci Rep)
Vol. 10
Issue 1
Pg. 21629
(12 10 2020)
ISSN: 2045-2322 [Electronic] England |
PMID | 33303808
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Inflammasomes
- NLR Family, Pyrin Domain-Containing 3 Protein
- Nlrp3 protein, rat
- Tumor Necrosis Factor-alpha
- 3-Hydroxybutyric Acid
|
Topics |
- 3-Hydroxybutyric Acid
(administration & dosage, blood)
- Animals
- Anxiety
(etiology, prevention & control)
- Disease Models, Animal
- Inflammasomes
(antagonists & inhibitors)
- Injections, Subcutaneous
- Male
- NLR Family, Pyrin Domain-Containing 3 Protein
(antagonists & inhibitors)
- Rats
- Rats, Sprague-Dawley
- Stress Disorders, Post-Traumatic
(complications)
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|